No photo of Olivier Feron
Calculated based on number of publications stored in Pure and citations from Scopus
20072022

Research activity per year

Network

Victor Delprat

Person: Scientific Staff researcher with a Term Contract

Caroline Bouzin

  • Angiogenesis and Cancer Research Laboratory
  • Université Catholique de Louvain
  • Pharmacology and Therapeutics Unit (FATH), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain
  • Pole of Pharmacology and Therapeutics (FATH)
  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Croix du Sud
  • Faculté de Medecine, UCL

External person

Pierre Sonveaux

  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Université Catholique de Louvain
  • Pole of Pharmacology and Therapeutics (FATH)
  • Croix du Sud

External person

Linda Karmani

  • Biomedical Magnetic Resonance Group (REMA), Louvain Drug Research Institute, Université Catholique de Louvain, B-1200 Woluwé, Saint Lambert, Belgium.

External person

Chantal Dessy

  • Université Catholique de Louvain
  • Faculté de Medecine, UCL

External person

Géraldine Rath

  • Université Catholique de Louvain

External person

Anne Bol

  • Centre for Molecular Imaging, Radiotherapy and Oncology (MIRO), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain
  • UCL-CMFA 7340

External person

Florence DEFRESNE

  • Angiogenesis and Cancer Research Laboratory
  • Pole of Pharmacology and Therapeutics (FATH)
  • Université Catholique de Louvain

External person

Vincent Grégoire

  • Centre for Molecular Imaging, Radiotherapy and Oncology (MIRO), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels

External person

Cyril Corbet

  • Université Catholique de Louvain

External person

M. Grandjean

  • Angiogenesis and Cancer Research Laboratory

External person

Philippe Levêque

  • Biomedical Magnetic Resonance Group (REMA), Louvain Drug Research Institute, Université Catholique de Louvain, B-1200 Woluwé, Saint Lambert, Belgium.
  • Louvain Drug Research Institute
  • Université Catholique de Louvain

External person

Céline Guilbaud

  • Angiogenesis and Cancer Research Laboratory
  • Pole of Pharmacology and Therapeutics (FATH)
  • Université Catholique de Louvain

External person

Chris Albanese

  • Lombardi Comprehensive Cancer Center
  • Georgetown University
  • Georgetown University Medical Center

External person

Jerome Zola

  • University of Namur

External person

Guillermo M. Albaiceta

  • Universidad de Oviedo
  • Hospital Universitario Central de Asturias (Oviedo)
  • Instituto Universitario de Oncologia del Principado de Asturias (Oviedo)

External person

Iraide Alloza

  • Achucarro Basque Center for Neuroscience (Leioa)
  • University of the Basque Country (EHU-UPV)
  • IKERBASQUE, Basque Foundation for Science

External person

Paolo E. Porporato

  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Université Catholique de Louvain
  • Pole of Pharmacology and Therapeutics (FATH)
  • Sezione di Pisa
  • Croix du Sud

External person

Emmanuel T. Akporiaye

  • Veana Therapeutics Inc. (Portland)
  • Providence Cancer Center (Portland)

External person

Akihisa Abe

  • Tokyo Medical University

External person

Hana Algül

  • Technical University of Munich
  • Klinik und Poliklinik für Innere Medizin II, Technische Universität München
  • Klinikum rechts der Isar der Technischen Universität München

External person

Edoardo M. Airoldi

  • Broad Institute
  • Fox School of Business (Philadelphia)
  • Massachusetts Institute of Technology

External person

ChristopheJ DeSaedeleer

  • Université Catholique de Louvain

External person

Charline Degavre

  • Université Catholique de Louvain

External person

Séverine Ravez

  • Jean Pierre Aubert Research Center, Team 5
  • EA 2693, Université Lille Nord de France
  • Institut National de la Santé et de la Recherche Médicale
  • Université Catholique de Louvain

External person

Maylin Almonte-Beceril

  • Aging Inflamation and Regenerative Medicine

External person

Hagai Abeliovich

  • The Hebrew University of Jerusalem

External person

Peter David Adams

  • Beatson Institute for Cancer Research
  • University of Glasgow
  • Sanford-Burnham-Prebys Medical Discovery Institute

External person

Virginie Blasioli

  • Université Libre de Bruxelles

External person

Giuseppina Amadoro

  • CNR
  • Institute of Translational Pharmacology (IFT)

External person

Patricia V. Aguilar

  • UT Medical Branch at Galveston
  • Institute for Human Infections and Immunity (Galveston)
  • Instituto Evandro Chagas

External person

Emeline Dierge

  • Université Catholique de Louvain

External person

Abraham Acevedo-Arozena

  • MRC Harwell
  • Universidad de la Laguna

External person

Jhudit Pérez-Escuredo

  • Université Catholique de Louvain
  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Pole of Pharmacology and Therapeutics (FATH)

External person

Robert James Gillies

  • H. Lee Moffitt Cancer Center and Research Institute

External person

Gladys Deumer

  • Louvain Centre for Toxicology and Applied Pharmacology-Institut de Recherche Expérimentale et Clinique

External person

Covadonga Alonso

  • Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (Madrid)
  • Consejo Superior de Investigaciones Científicas (C.S.I.C.)

External person

Rajesh Agarwal

  • University of Colorado

External person

Stéphan H. M. Walrand

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Daniel J. Klionsky

  • University of Michigan, Ann Arbor

External person

Joao Pedro Santiago de Jesus

  • Université Catholique de Louvain

External person

Luc Vanhamme

  • Université Libre de Bruxelles

External person

Fabrice Soncin

  • EA 2693, Université Lille Nord de France

External person

Dider Vertommen

  • de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 75, Brussels 1200, Belgium.

External person

Miguel Romero-Perez

  • University of Granada

External person

Morgane Tardy

  • Université Catholique de Louvain
  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Pole of Pharmacology and Therapeutics (FATH)

External person

Philippe Cauchie

  • Université Libre de Bruxelles

External person

Daniel Labar

  • Centre for Molecular Imaging, Radiotherapy and Oncology (MIRO), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain

External person

Matthew L. Albert

  • Institut Pasteur, Paris
  • Genentech Incorporated (San Francisco)

External person

Patrizia M. Agostinis

  • KULeuven
  • Departement Cellulaire en Moleculaire Geneeskunde (Leuven)
  • Flanders Interuniversity Institute for Biotechnology (VIB)

External person

Manish K. Aghi

  • University of California, San Francisco

External person

Estelle Bastien

  • Université Catholique de Louvain
  • CRAN Centre de Recherche en Automatique de Nancy

External person

Silvia Pastoreková

  • Biomedical Research Center of the Slovak Academy of Sciences

External person

Vincent Haufroid

  • Louvain Centre for Toxicology and Applied Pharmacology-Institut de Recherche Expérimentale et Clinique
  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels
  • Croix du Sud
  • Faculté de Medecine, UCL

External person

Atsuo Amano

  • NICT and Osaka University
  • Kanazawa University
  • Japan Science and Technology Agency

External person

Sharon G. Adler

  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
  • The Lundquist Institute (Torrance)

External person

Catherine Vander Linden

  • Université Catholique de Louvain

External person

Maria Agnello

  • Università di Palermo

External person

Takahiko Akematsu

  • Universität Wien

External person

Yves Decrem

  • Université Libre de Bruxelles

External person

Nicola Baldini

  • Rizzoli Orthopaedic Institute
  • Alma Mater Studiorum Università di Bologna

External person

Thibaut Vazeille

  • Université Catholique de Louvain
  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Pole of Pharmacology and Therapeutics (FATH)
  • Croix du Sud

External person

Jean-Marie Frère

  • Université de Liège

External person

Sofia Avnet

  • Rizzoli Orthopaedic Institute
  • Alma Mater Studiorum Università di Bologna

External person

Khosrow Adeli

  • Hospital for Sick Children University of Toronto
  • University of Toronto

External person

Diego Albani

  • Istituto di Ricerche Farmacologiche Mario Negri (IRCCS)
  • Laboratory of Medical Genetics and Neurogenetics, Foundation IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

External person

Pierre Danhier

  • Université Catholique de Louvain
  • CHU UCL Mont-Godinne-Dinant
  • Biomedical Magnetic Resonance Group (REMA), Louvain Drug Research Institute, Université Catholique de Louvain, B-1200 Woluwé, Saint Lambert, Belgium.

External person

Kotb Abdelmohsen

  • National Institute on Aging

External person

Hiroaki Adachi

  • University of Occupational and Environmental Health School of Medicine

External person

Dario C. Altieri

  • The Wistar Institute

External person

Quentin SPILLIER

  • Université Catholique de Louvain

External person

Romain Marteau

  • Université Catholique de Louvain

External person

Bernard Gallez

  • Biomedical Magnetic Resonance Group (REMA), Louvain Drug Research Institute, Université Catholique de Louvain, B-1200 Woluwé, Saint Lambert, Belgium.
  • Université Catholique de Louvain

External person

Claudiu T. Supuran

  • Department of Mathematics and Computer Science, University of Florence

External person

C. Kupatt

  • Klinikum Großhadern

External person

Alexandru Almasan

  • Cleveland Clinic Lerner Research Institute
  • Cleveland-Clinic Taussig Cancer Institute
  • CASE School of Medecine (Cleveland)

External person

Tamara Copetti

  • Université Catholique de Louvain
  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Pole of Pharmacology and Therapeutics (FATH)

External person

Laure Finet

  • Université Catholique de Louvain

External person

Ruben Martherus

  • Université Catholique de Louvain

External person

Suveera Dhup

  • Université Catholique de Louvain
  • Université Catholique de Louvain, Institut de Recherche Clinique et Expérimentale (IREC), Laboratory of Pediatric Hepatology and Cell Therapy, Brussels, Belgium. Electronic address: etienne.sokal@uclouvain.be.
  • Pole of Pharmacology and Therapeutics (FATH)

External person

Slimane Ait-Si-Ali

  • CNRS
  • Universite Paris Diderot
  • University Paris Saclay

External person

Christopher M. Adams

  • University of Iowa Healthcare
  • Stanford University

External person

Bastien Doix

  • Université Catholique de Louvain
  • CEA Fontenay aux Roses

External person

Edmond Godfroid

  • Université Libre de Bruxelles
  • Bioxodes S.A.

External person

Galila Agam

  • Ben-Gurion University of the Negev

External person

Angela M. Otto

  • Technical University of Munich

External person

A.K. Hatzopoulos

  • Vanderbilt University

External person

Md Joynal Abedin

  • University of Minnesota

External person

Elvira León-Gómez

  • Université Catholique de Louvain

External person

ValéryL Payen

  • Université Catholique de Louvain

External person

Mohamed Al-Rubeai

  • School of Mathematics and Statistics, University College Dublin
  • Cihan University-Erbil

External person

Lydia Alvarez-Erviti

  • University College London

External person

Jesus Aldudo

  • Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)
  • Instituto de Investigación Sanitaria La Fe (Valencia)
  • Universidad Autónoma de Madrid (UAM)

External person

Silvia Álvarez

  • Universidad de Buenos Aires

External person

Angelo De Milito

  • Karolinska Institute
  • Karolinska University Hospital

External person

Stine Falsig Pedersen

  • University of Copenhagen

External person

Peter J. Adhihetty

  • University of Florida
  • Schulich School of Business-York University (Toronto)

External person

Sandro Alves

  • Gene Therapy for Neurodegenerative Diseases
  • Hôpital La Pitié Salpêtrière (AP-HP)

External person

Thierry Vander Borght

  • NARILIS
  • CHU UCL Mont-Godinne-Dinant

External person

Jérôme Beaufays

  • Université Libre de Bruxelles

External person

Nihal Altan-Bonnet

  • National Heart, Lung, and Blood Institute

External person

Mehrdad Alirezaei

  • Scripps Research Institute (San Diego)
  • Institut National de la Santé et de la Recherche Médicale

External person

Irina I. Lobysheva

  • Université Catholique de Louvain

External person

Consuelo Amantini

  • University of Camerino
  • Università degli Studi di Roma La Sapienza
  • Istituto Superiore di Sanità

External person

Julio A. Aguirre-Ghiso

  • Icahn School of Medicine at Mount Sinai

External person

PaoloE Porporato

  • Université Catholique de Louvain

External person

Emad S. Alnemri

  • Thomas Jefferson University
  • Sidney Kimmel Cancer Center at Jefferson (Philadelphia)

External person

Your message has successfully been sent.
Your message was not sent due to an error.